The biopharmaceutical industry has experienced incredible exponential growth in recent decades.
A primary driver of this growth is the pursuit of biologics to treat the growing rate of chronic diseases. Other factors fueling the industry’s robust economic growth are technological advancements, such as the use of smart data, machine learning and wireless connectivity, and the ongoing progress towards developing new products and services to better meet patients’ needs and the challenges they confront in the daily use of their prescribed therapeutics.
In this article, Joe Reynolds, Senior Manager, Strategy and Patient Insights at Noble, discusses the role training devices and patient education play with regard to self-injection therapies. Noble is a global leader in the development and delivery of medical device training solutions, patient onboarding strategies and multisensory products for patients, and HCPs that aim to improve patient adherence and healthy outcomes.
Review the evolution of injection devices and prefilled syringes, the benefits of training devices combined with patient education, and an empirical look at patient training.